J. Craig Venter has stepped down from the board of directors of US Genomics, the company said last week. He is replaced by Salvatore Salamone, who is chairman and CEO of Saladax Biomedical and was formerly vice president of R&D at Roche Diagnostics.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.